Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajit Jadhav

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Nature Communications|August 3, 2013
Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasionPrakash Srinivasan, Adam Yasgar, Diane K Luci, et al.
Biochemistry|April 1, 2016
Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine ProteaseXin Hu, Jaimee R Compton, Dagmar H Leary, et al.
Journal of Medicinal Chemistry|July 25, 2015
Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1)Shyh-Ming Yang, Adam Yasgar, Bettina Miller, et al.
Pain|August 22, 2018
Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male ratsAnn M Gregus, Matthew W Buczynski, Darren S Dumlao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2017
A high-throughput small molecule screen identifies synergism between DNA methylation and Aurora kinase pathways for X reactivationDerek Lessing, Thomas O Dial, Chunyao Wei, et al.
Oncotarget|May 17, 2014
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapyRachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, et al.
Medchemcomm|December 4, 2012
A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases()Bryan T Mott, Ken Chih-Chien Cheng, Rajarshi Guha, et al.
Journal of Medicinal Chemistry|April 2, 2014
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapiesGanesha Rai, Netra Joshi, Joo Eun Jung, et al.
Nature Communications|February 6, 2015
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Nature Communications|February 4, 2016
Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Nature Communications|August 3, 2013
Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasionPrakash Srinivasan, Adam Yasgar, Diane K Luci, et al.
Biochemistry|April 1, 2016
Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine ProteaseXin Hu, Jaimee R Compton, Dagmar H Leary, et al.
Journal of Medicinal Chemistry|July 25, 2015
Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1)Shyh-Ming Yang, Adam Yasgar, Bettina Miller, et al.
Pain|August 22, 2018
Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male ratsAnn M Gregus, Matthew W Buczynski, Darren S Dumlao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2017
A high-throughput small molecule screen identifies synergism between DNA methylation and Aurora kinase pathways for X reactivationDerek Lessing, Thomas O Dial, Chunyao Wei, et al.
Oncotarget|May 17, 2014
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapyRachel Abbotts, Rosalyn Jewell, Jérémie Nsengimana, et al.
Medchemcomm|December 4, 2012
A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases()Bryan T Mott, Ken Chih-Chien Cheng, Rajarshi Guha, et al.
Journal of Medicinal Chemistry|April 2, 2014
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapiesGanesha Rai, Netra Joshi, Joo Eun Jung, et al.
Nature Communications|February 6, 2015
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Nature Communications|February 4, 2016
Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacyHilary A Kenny, Madhu Lal-Nag, Erin A White, et al.
Pageof 17